Michael R. Wood - Concepedia

Author

Michael R. Wood

Vanderbilt University

Also Known As

M R Wood, M Wood, M. R. WOOD, M. R. Wood, M. WOOD, M. Wood, MICHAEL WOOD, Michael R Wood, Michael R. Wood, Michael Wood

173

Publications

3.8K

Citations

H-Index

109

Concepts

All Affiliations

Vanderbilt University Vanderbilt University Medical Center AstraZeneca (United States)United States Military Academy John F. Kennedy Center for the Performing Arts

About

Michael R. Wood is an author at Vanderbilt University specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	1.2K
2	Engineering	6	6	197
3	Health Sciences	2	2	39
4	Arts	1	1	19
5	Education	1	1	19

Michael R. Wood

Publications

Citations

H-Index

Page 1

	Year	Citations
Total Syntheses of Vancomycin and Eremomycin Aglycons David A. Evans, Michael R. Wood, B. Wesley Trotter, Angewandte Chemie International Edition Medicinal ChemistryBioorganic ChemistryGlycosylationBiochemistryNatural Sciences	1998	263
Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery Bruce J. Melancon, Corey R. Hopkins, Michael R. Wood, Journal of Medicinal Chemistry Drug TargetSynaptic TransmissionAltmetric Attention ScoreCellular PharmacologyPeptide Science	2011	222
Nonconventional Stereochemical Issues in the Design of the Synthesis of the Vancomycin Antibiotics: Challenges Imposed by Axial and Nonplanar Chiral Elements in the Heptapeptide Aglycons David A. Evans, Christopher J. Dinsmore, Paul S. Watson, Angewandte Chemie International Edition Bioorganic ChemistryAntibiotic AdjuvantGlycobiologyMolecular BiologyOrganic Chemistry	1998	160
Selective Activation of M<sub>4</sub>Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents Michael Bubser, Thomas M. Bridges, Ditte Dencker, ACS Chemical Neuroscience	2014	150
Antipsychotic Drug-Like Effects of the Selective M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator VU0152100 Nellie Byun, Michael Grannan, Michael Bubser, Neuropsychopharmacology PsychiatryFunctional SelectivityMedicinePsychopharmacologySchizophrenia	2014	119
Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model Ayan Ghoshal, Jerri M. Rook, Jonathan W. Dickerson, Neuropsychopharmacology Synaptic PlasticityNeuropsychologyCognitive SymptomsPsychiatryMedicine	2015	102
A Practical, General Three-Component Coupling Approach to Prostaglandin and Non-Prostaglandin-Related Skeleta Bruce H. Lipshutz, Michael R. Wood Journal of the American Chemical Society Chemical AnalysisGlycobiologyAltmetric Attention ScoreMolecular BiologyBibliometrics	1994	85
Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate Jack Bibby, Harriet A. Purvis, Thomas S. Hayday, Nature Communications	2020	85
M<sub>5</sub>Receptor Activation Produces Opposing Physiological Outcomes in Dopamine Neurons Depending on the Receptor's Location Daniel J. Foster, Patrick R. Gentry, José E. Lizardi-Ortiz, Journal of Neuroscience	2014	80
Discovery of the First M<sub>5</sub>-Selective and CNS Penetrant Negative Allosteric Modulator (NAM) of a Muscarinic Acetylcholine Receptor: (<i>S</i>)-9b-(4-Chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1<i>H</i>-imidazo[2,1-<i>a</i>]isoindol-5(9b<i>H</i>)-one (ML375) Patrick R. Gentry, Masaya Kokubo, Thomas M. Bridges, Journal of Medicinal Chemistry	2013	72

Page 1